Skip to main content

Medicines labeled for the same conditions

Alternatives to abacavir

41 other medicines are given the same way (oral) and in the same FDA class as abacavir or labeled mainly for the same use (HIV); 18 are in its class, human immunodeficiency virus nucleoside analog reverse transcriptase inhibitors: emtricitabine and tenofovir disoproxil, lamivudine, tenofovir disoproxil, lamivudine and zidovudine and 14 more; the others include 6 human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitors, 5 cytochrome p450 3a inhibitors and 4 protease inhibitors (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.294 per tenofovir disoproxil fumarate 300 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).

Which medicines are labeled for the same conditions as abacavir?

The first 24 of the 41, the same class first. HIV lists all 47 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.

Medicine and FDA classShared indicationGeneric labelers (oral)Pharmacy costBoxed warningShortage
Abacavirhuman immunodeficiency virus nucleoside analog reverse transcriptase inhibitorthis medicine12 labelers$0.546 per tablet 300 mg tabletYesNo current entry
Emtricitabine and tenofovir disoproxilhepatitis b virus nucleoside analog reverse transcriptase inhibitor · same classHIV25 labelers$0.529 per tablet 200-300 mg tabletYesNo current entry
Lamivudinehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same classHIV14 labelers$0.489 per tablet 150 mg tabletYesNo current entry
Tenofovir disoproxilhepatitis b virus nucleoside analog reverse transcriptase inhibitor · same classHIV15 labelers$0.294 per tablet 300 mg tabletYesNo current entry
Lamivudine and zidovudinehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same classHIV7 labelers$0.771 per tablet Lamivudine-zidovudine tabletYesNo current entry
Efavirenz and emtricitabine and tenofovir disoproxilhuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same classHIV7 labelers$1.12 per tablet 600-200-300 mg tabletYesNo current entry
Zidovudinehuman immunodeficiency virus nucleoside analog reverse transcriptase inhibitor · same classHIV3 labelers$0.464 per tablet 300 mg tabletYesNo current entry
Bictegravir and emtricitabine and tenofovir alafenamidehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same classHIVnone listed$136.73 per tablet 50-200-25 mg tabletYesNo current entry
Emtricitabinehuman immunodeficiency virus nucleoside analog reverse transcriptase inhibitor · same classHIV2 labelers$12.69 per capsule 200 mg capsuleYesA presentation being discontinued
Efavirenz and lamivudine and tenofovir disoproxilhuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same classHIV1 labelern/aYesNo current entry
Emtricitabine and rilpivirine and tenofovir disoproxilhuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same classHIV2 labelers$114.50 per tablet 200-25-300 mg tabletYesNo current entry
Emtricitabine and tenofovir alafenamidehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same classHIVnone listed$74.94 per tablet 200-25 mg tabletYesNo current entry
Cobicistat, darunavir, emtricitabine and tenofovir alafenamidecytochrome p450 3a inhibitor · same classHIVnone listed$152.87 per tablet 800-150-200-10 mg tabletYesNo current entry
Cobicistat, elvitegravir, emtricitabine and tenofovir alafenamidecytochrome p450 3a inhibitor · same classHIVnone listed$143.35 per tablet Genvoya tabletYesNo current entry
Cobicistat, elvitegravir, emtricitabine and tenofovir disoproxilcytochrome p450 3a inhibitor · same classHIVnone listed$150.14 per tablet Stribild tabletYesNo current entry
Dolutegravir and lamivudinehuman immunodeficiency virus integrase strand transfer inhibitor · same classHIVnone listed$105.22 per tablet 50-300 mg tabletYesNo current entry
Doravirine and lamivudine and tenofovir disoproxilhuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same classHIVnone listed$93.06 per tablet 100-300-300 mg tabletYesNo current entry
Emtricitabine and rilpivirine and tenofovir alafenamidehuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same classHIVnone listed$130.49 per tablet Odefsey tabletYesNo current entry
Lamivudine and tenofovir disoproxilhepatitis b virus nucleoside analog reverse transcriptase inhibitor · same classHIVnone listedn/aYesNo current entry
Darunavirprotease inhibitorHIV13 labelers$1.16 per tablet 600 mg tabletNoNo current entry
Maravirocccr5 co-receptor antagonistHIV8 labelers$9.15 per tablet 150 mg tabletYesA presentation being discontinued
Atazanavirprotease inhibitorHIV4 labelers$2.23 per capsule 300 mg capsuleNoNo current entry
Etravirinehuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitorHIV5 labelers$9.94 per tablet 200 mg tabletNoA presentation being discontinued
Ritonavircytochrome p450 3a inhibitorHIV7 labelers$0.607 per tablet 100 mg tabletYesA presentation being discontinued
Lopinavir and ritonavircytochrome p450 3a inhibitorHIV3 labelers$4.46 per tablet 200-50 mg tabletNoA presentation being discontinued

Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)

What do pharmacies pay for each?

The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Abacavir: the full record
label, generics, price, shortages, recalls